Product Information
REFRESH PLUS 0.5% EYE DROPS is a brand product labeled by Allergan, Inc., priced at $0.2968 per EA under NDC 00023040330. Its NADAC has been published 462 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the carboxymethylcellulose sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Allergan, Inc.NDC
00023040330
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
10/9/1996
Price Statistics
The NADAC for REFRESH PLUS 0.5% EYE DROPS has been published 462 times since Nov 28, 2013, and over the history we have for it it has risen 18.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2968 per EA |
|---|---|
| All-time high | $0.2969 (Aug 12, 2026) |
| All-time low | $0.2510 (Aug 20, 2014) |
| 52-week high | $0.2969 |
| 52-week low | $0.2966 |
| Median price | $0.2767 |
| Average price | $0.2779 |
| Largest weekly change | +12.1% (Mar 12, 2014) |
| Weeks tracked | 462 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
carboxymethylcellulose sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REFRESH PLUS 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for REFRESH PLUS 0.5% EYE DROPS, manufactured by Allergan, Inc., is $0.2968 per EA (NDC 00023040330), effective Sep 30, 2026.
How has the price of REFRESH PLUS 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for REFRESH PLUS 0.5% EYE DROPS has risen 18.1%. It has been tracked across 462 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for REFRESH PLUS 0.5% EYE DROPS?
Since Nov 28, 2013, the NADAC for REFRESH PLUS 0.5% EYE DROPS has ranged from a low of $0.2510 (Aug 20, 2014) to a high of $0.2969 (Aug 12, 2026), with a median of $0.2767 per EA.
Are there cheaper alternatives to REFRESH PLUS 0.5% EYE DROPS?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBOXYMETHYLCELL 0.5% EYE DRP, is $0.1628 per EA — about 45% below REFRESH PLUS 0.5% EYE DROPS.
Who manufactures REFRESH PLUS 0.5% EYE DROPS?
REFRESH PLUS 0.5% EYE DROPS (NDC 00023040330) is labeled by Allergan, Inc., and CMS classifies it as a brand product.